Millet, Yves A
Synlogic (United States)
2 papers on CoChatORCID 0000-0002-7001-7030
Most cited papers
- Verified
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
Isabella, V. M., Ha, B. N., Castillo, M. J., Lubkowicz, D. J., Rowe, S. E., Millet, Y. A., Anderson, C. L., Li, N., Fisher, A. B., West, K. A., et al. (2018) · Nature Biotechnology
Bacterial Cancer TherapyProbiotics and Fermented Foods
Cited by 605
- Verified
An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans
Kurtz, C. B., Millet, Y. A., Puurunen, M. K., Perreault, M., Charbonneau, M. R., Isabella, V. M., Kotula, J. W., Antipov, E., Dagon, Y., Denney, W. S., et al. (2019) · Science Translational Medicine
Bacterial Cancer TherapyAmino Acid Enzymes and Metabolism
Cited by 399
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free